PL3536807T3 - Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza - Google Patents

Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza

Info

Publication number
PL3536807T3
PL3536807T3 PL19171630.7T PL19171630T PL3536807T3 PL 3536807 T3 PL3536807 T3 PL 3536807T3 PL 19171630 T PL19171630 T PL 19171630T PL 3536807 T3 PL3536807 T3 PL 3536807T3
Authority
PL
Poland
Prior art keywords
methylome
tumor
plasma
invasive determination
invasive
Prior art date
Application number
PL19171630.7T
Other languages
English (en)
Inventor
Rossa Wai Kwun Chiu
Kwan Chee Chan
Yuk-Ming Dennis Lo
Miu Fan Lun
Peiyong Jiang
Wai Man Chan
Original Assignee
The Chinese University Of Hong Kong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3536807(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by The Chinese University Of Hong Kong filed Critical The Chinese University Of Hong Kong
Publication of PL3536807T3 publication Critical patent/PL3536807T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
PL19171630.7T 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza PL3536807T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03

Publications (1)

Publication Number Publication Date
PL3536807T3 true PL3536807T3 (pl) 2024-05-06

Family

ID=50340462

Family Applications (4)

Application Number Title Priority Date Filing Date
PL13838770.9T PL2898100T5 (pl) 2012-09-20 2013-09-20 Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza
PL19171630.7T PL3536807T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL17202149T PL3354747T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL22171427.2T PL4056712T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza w osoczu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13838770.9T PL2898100T5 (pl) 2012-09-20 2013-09-20 Nieinwazyjny sposób określania metylomu płodu lub guza z wykorzystaniem osocza

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL17202149T PL3354747T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza z wykorzystaniem osocza
PL22171427.2T PL4056712T3 (pl) 2012-09-20 2013-09-20 Nieinwazyjne określanie metylomu guza w osoczu

Country Status (28)

Country Link
EP (6) EP3839065A1 (pl)
JP (6) JP6317354B2 (pl)
KR (5) KR102587176B1 (pl)
CN (2) CN117757932A (pl)
AU (5) AU2013317708C1 (pl)
BR (3) BR112015006183B1 (pl)
CA (2) CA2884066C (pl)
CY (1) CY1124139T1 (pl)
DK (4) DK4056712T3 (pl)
EA (1) EA201500327A1 (pl)
ES (4) ES2969567T3 (pl)
FI (2) FI4056712T3 (pl)
HR (3) HRP20241142T1 (pl)
HU (3) HUE053822T2 (pl)
IL (4) IL313451A (pl)
LT (2) LT3354747T (pl)
MX (1) MX360034B (pl)
MY (2) MY187444A (pl)
NZ (2) NZ706269A (pl)
PH (2) PH12022552061A1 (pl)
PL (4) PL2898100T5 (pl)
PT (4) PT3536807T (pl)
SG (2) SG11201501927VA (pl)
SI (1) SI4056712T1 (pl)
SM (1) SMT202100256T1 (pl)
TW (5) TWI707953B (pl)
WO (1) WO2014043763A1 (pl)
ZA (1) ZA201501772B (pl)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
BR112015006183B1 (pt) * 2012-09-20 2022-04-26 The Chinese University Of Hong Kong Métodos para analisar uma amostra biológica de um organismo, para determinar um primeiro perfil de metilação de uma amostra biológica de um organismo, para detecção de uma anormalidade cromossômica de uma amostra biológica de um organismo e para estimar um nível de metilação do dna em uma amostra biológica de um organismo, produto de computador, e, kit para análise de dna fetal
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3029148B1 (en) * 2013-07-30 2018-06-27 BGI Genomics Co., Limited Method for determining nucleic acid composition of nucleic acid mixture
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
CA2945962C (en) * 2014-04-21 2023-08-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
MA39951A (fr) 2014-05-09 2017-03-15 Lifecodexx Ag Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
EP3543356B1 (en) * 2014-07-18 2021-06-30 The Chinese University of Hong Kong Methylation pattern analysis of tissues in dna mixture
KR102696857B1 (ko) 2014-07-25 2024-08-19 유니버시티 오브 워싱톤 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법
EP4574996B1 (en) 2014-12-31 2025-11-05 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) * 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
PT3256605T (pt) 2015-02-10 2022-03-17 Univ Hong Kong Chinese Deteção de mutações para rastreio de cancro e análise fetal
EP3325663B1 (en) * 2015-07-20 2020-08-19 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
TWI730973B (zh) 2015-07-23 2021-06-21 香港中文大學 游離ｄｎａ(ｃｅｌｌ-ｆｒｅｅ ｄｎａ)之片段化模式分析
CN115433769A (zh) 2015-08-12 2022-12-06 香港中文大学 血浆dna的单分子测序
TWI767888B (zh) 2015-09-22 2022-06-21 香港中文大學 藉由母體血漿ｄｎａ之淺深度測序以準確定量胎兒ｄｎａ含量
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
WO2017083366A1 (en) * 2015-11-09 2017-05-18 Progenity, Inc. Methods for determining the origin of dna molecules
DK3168309T3 (da) 2015-11-10 2020-06-22 Eurofins Lifecodexx Gmbh Detektion af føtale kromosomale aneuploidier under anvendelse af dna-regioner med forskellig metylering mellem fosteret og det gravide hunkøn
CA3168463A1 (en) 2015-12-17 2017-06-22 Illumina, Inc. Distinguishing methylation levels in complex biological samples
US11335463B2 (en) * 2016-02-02 2022-05-17 Guardant Health, Inc. Cancer evolution detection and diagnostic
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
JP6979554B2 (ja) 2016-05-03 2021-12-15 ユニバーシティー ヘルス ネットワーク 無細胞メチル化ｄｎａを捕捉する方法及びその使用
US12300356B2 (en) 2016-05-04 2025-05-13 Queen's University At Kingston Cell-free detection of methylated tumour DNA
EP4324937B1 (en) * 2016-05-30 2026-01-21 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood
ES2897550T3 (es) * 2016-06-16 2022-03-01 Univ Johns Hopkins Métodos y sistema de análisis epigenético
US11999998B2 (en) 2016-08-24 2024-06-04 Center For Excellence In Molecular Cell Science, Chinese Academy Of Sciences Modification of 5-methylcytosine catalyzed by Cmd1 enzyme and application thereof
EP3529377B1 (en) * 2016-10-19 2023-04-05 The Chinese University Of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
WO2018081130A1 (en) 2016-10-24 2018-05-03 The Chinese University Of Hong Kong Methods and systems for tumor detection
KR20260032575A (ko) * 2016-11-30 2026-03-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
US20190309374A1 (en) * 2016-12-13 2019-10-10 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
CN110770341A (zh) * 2017-01-11 2020-02-07 奎斯特诊断投资有限责任公司 非整倍性无创产前筛查方法
ES2981092T3 (es) * 2017-01-24 2024-10-07 Bgi Genomics Co Ltd Procedimiento para determinar la proporción de ácidos nucleicos acelulares procedentes de una fuente predeterminada en una muestra biológica
EP4421489B1 (en) 2017-01-25 2026-03-11 The Chinese University of Hong Kong Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CN111417731A (zh) * 2017-05-12 2020-07-14 哈佛学院校长同事会 通用早期癌症诊断
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
EP3652740A2 (en) * 2017-07-12 2020-05-20 ANDE Corporation Pattern recognition system
KR102628878B1 (ko) * 2017-07-12 2024-01-23 유니버시티 헬스 네트워크 메틸롬 분석을 이용한 암 검출 및 분류
KR20250171389A (ko) * 2017-07-26 2025-12-08 더 차이니즈 유니버시티 오브 홍콩 세포-무함유 바이러스 핵산을 사용하는 암 스크리닝의 증강
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
EP4026915B1 (en) 2017-09-28 2023-10-25 Grail, LLC Enrichment of short nucleic acid fragments in sequencing library preparation
US11168356B2 (en) * 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
AU2019234843B2 (en) 2018-03-13 2025-12-04 Grail, Inc. Anomalous fragment detection and classification
WO2019178496A1 (en) 2018-03-15 2019-09-19 Grail, Inc. Tissue-specific methylation marker
WO2019195268A2 (en) 2018-04-02 2019-10-10 Grail, Inc. Methylation markers and targeted methylation probe panels
CA3095056A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
EP3781709A4 (en) * 2018-04-16 2022-11-30 Grail, LLC Systems and methods for determining tumor fraction in cell-free nucleic acid
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
CA3111887A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
KR20210141915A (ko) 2018-11-21 2021-11-23 아비다 바이오메드 인코포레이티드 표적화된 핵산 라이브러리 형성을 위한 방법
EP4542551A3 (en) * 2018-12-19 2025-07-16 The Chinese University of Hong Kong Cell-free dna end characteristics
EP3899953A1 (en) 2018-12-21 2021-10-27 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
EP4485464A3 (en) 2019-02-05 2025-02-19 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
CA3130810A1 (en) 2019-03-25 2020-10-01 The Chinese University Of Hong Kong Determining linear and circular forms of circulating nucleic acids
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
JP2022530920A (ja) * 2019-05-03 2022-07-04 コーネル ユニバーシティー 核酸配列の変異、発現、スプライスバリアント、転座、コピー数、またはメチル化変化を特定及び定量するためのマーカー
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
CA3147613A1 (en) * 2019-08-19 2021-02-25 Chang-Seok Ki Method for detecting chromosomal abnormality by using information about distance between nucleic acid fragments
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
CA3158101A1 (en) * 2019-11-27 2021-06-03 M. Cyrus MAHER Systems and methods for evaluating longitudinal biological feature data
JP7732991B2 (ja) 2020-01-31 2025-09-02 アジレント・テクノロジーズ・インク 標的化された核酸捕捉のためのシステムおよび方法
JP2023516276A (ja) * 2020-02-10 2023-04-19 パロゲン，インコーポレイテッド ナノポアデバイスおよびそれを用いる荷電粒子の検出・分類方法
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
JP2023514851A (ja) * 2020-02-28 2023-04-11 グレイル エルエルシー 癌の病態を判別または示すメチル化パターンの同定
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
IL302988A (en) * 2020-11-19 2023-07-01 Nucleix Ltd Detection of methylation changes in DNA samples using restriction enzymes and high-throughput sequencing
AU2021401813A1 (en) * 2020-12-17 2023-07-06 Dana-Farber Cancer Institute, Inc. Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
US20240371467A1 (en) * 2021-09-28 2024-11-07 Act Genomics (ip) Limited Methylation biomarker selection apparatuses and methods
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
US20230138633A1 (en) * 2021-11-04 2023-05-04 Universal Diagnostics, S.L. Systems and methods for preparing biological samples for genetic sequencing
CN119301278A (zh) 2022-02-07 2025-01-10 创新诊断科技中心 用于测量甲基化和疾病的片段化
WO2023164017A2 (en) * 2022-02-22 2023-08-31 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024112893A1 (en) * 2022-11-23 2024-05-30 Foundation Medicine, Inc. Systems and methods for tracking personalized methylation biomarkers for the detection of disease
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN116555426B (zh) * 2023-05-04 2024-07-12 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒及数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) * 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
EP1342794B1 (en) 2002-03-05 2005-12-14 Epigenomics AG Method and device for determination of tissue specificity of free floating DNA in bodily fluids
AU2003294315A1 (en) * 2002-11-19 2004-06-15 Amgen Inc. Amplified genes involved in cancer
US20060183128A1 (en) 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
EP2380993B1 (en) * 2004-03-08 2015-12-23 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
AU2006251937A1 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating DNA for diagnosis, prognosis, and treatment of cancer
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
TWI335354B (en) * 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
KR20220146689A (ko) 2007-07-23 2022-11-01 더 차이니즈 유니버시티 오브 홍콩 핵산 서열 불균형의 결정
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
WO2011038507A1 (en) 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
PL2496717T3 (pl) * 2009-11-05 2017-11-30 The Chinese University Of Hong Kong Analiza genomowa płodu z matczynej próbki biologicznej
MX357692B (es) 2009-11-06 2018-07-19 Univ Hong Kong Chinese Analisis genomico a base de tamaño.
US10662474B2 (en) * 2010-01-19 2020-05-26 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
DK2529032T3 (en) * 2010-01-26 2017-05-01 Nipd Genetics Ltd METHODS AND COMPOSITIONS FOR NON-INVASIVE PRE-NATIONAL DIAGNOSTICATION OF Fetal ANEUPLOIDITIES
CA3052912A1 (en) 2010-04-29 2011-11-10 The Regents Of The University Of California Pathway recognition algorithm using data integration on genomic models (paradigm)
GB201007944D0 (en) 2010-05-12 2010-06-30 Univ Aberystwyth Methods
WO2011150075A2 (en) 2010-05-25 2011-12-01 The Johns Hopkins University Compositions and methods for detecting a neoplasia
EP2596127A2 (en) * 2010-07-23 2013-05-29 Esoterix Genetic Laboratories, LLC Identification of differentially represented fetal or maternal genomic regions and uses thereof
EP4303584A3 (en) * 2010-07-23 2024-04-03 President and Fellows of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
EP4269623A3 (en) 2010-11-30 2024-03-06 The Chinese University Of Hong Kong Analysis of a biological sample of an organism for chromosomal deletions or amplifications associated with cancer
BR112015006183B1 (pt) * 2012-09-20 2022-04-26 The Chinese University Of Hong Kong Métodos para analisar uma amostra biológica de um organismo, para determinar um primeiro perfil de metilação de uma amostra biológica de um organismo, para detecção de uma anormalidade cromossômica de uma amostra biológica de um organismo e para estimar um nível de metilação do dna em uma amostra biológica de um organismo, produto de computador, e, kit para análise de dna fetal

Also Published As

Publication number Publication date
PH12015500547B1 (en) 2024-05-17
TW202334438A (zh) 2023-09-01
CN117757932A (zh) 2024-03-26
ES2994426T3 (en) 2025-01-23
TWI707953B (zh) 2020-10-21
AU2017251832A1 (en) 2017-11-16
DK3354747T3 (da) 2021-04-19
BR122021021825B1 (pt) 2022-05-24
ES2862726T3 (es) 2021-10-07
EP4056712B1 (en) 2024-07-31
EP2898100B1 (en) 2017-11-22
EP2898100B9 (en) 2023-08-02
JP6985753B2 (ja) 2021-12-22
NZ706269A (en) 2016-08-26
MX2015003571A (es) 2015-06-22
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
EP3354747B1 (en) 2021-02-17
SG11201501927VA (en) 2015-04-29
CN104781422A (zh) 2015-07-15
EP4335929C0 (en) 2026-01-21
EP2898100A4 (en) 2016-05-11
EP3839065A1 (en) 2021-06-23
CY1124139T1 (el) 2022-05-27
TWI640634B (zh) 2018-11-11
AU2025205087A1 (en) 2025-07-24
IL299444B2 (en) 2024-11-01
IL237495A0 (en) 2015-04-30
JP6683752B2 (ja) 2020-04-22
EP2898100B2 (en) 2023-05-10
DK2898100T4 (da) 2023-07-24
SI4056712T1 (sl) 2024-10-30
HRP20240210T1 (hr) 2024-05-10
FI3536807T3 (fi) 2024-02-01
HUE068129T2 (hu) 2024-12-28
KR102587176B1 (ko) 2023-10-06
TWI806621B (zh) 2023-06-21
ES2665273T5 (es) 2023-10-02
KR20210120124A (ko) 2021-10-06
AU2022201026A1 (en) 2022-03-10
EP4056712A1 (en) 2022-09-14
HUE053822T2 (hu) 2021-07-28
PL2898100T3 (pl) 2018-06-29
DK2898100T3 (en) 2018-02-26
JP6317354B2 (ja) 2018-04-25
ES2665273T3 (es) 2018-04-25
HK1206797A1 (en) 2016-01-15
TW201907013A (zh) 2019-02-16
TW202043483A (zh) 2020-12-01
HUE066054T2 (hu) 2024-07-28
EP3536807B1 (en) 2023-11-29
AU2020200128B2 (en) 2021-11-18
JP2025026936A (ja) 2025-02-26
HK1207124A1 (en) 2016-01-22
KR20230145530A (ko) 2023-10-17
AU2020200128A1 (en) 2020-01-30
AU2013317708B2 (en) 2017-08-03
DK4056712T3 (da) 2024-08-26
TW201418474A (zh) 2014-05-16
TW202305145A (zh) 2023-02-01
KR102307424B1 (ko) 2021-09-29
ES2969567T3 (es) 2024-05-21
EP2898100A1 (en) 2015-07-29
TWI784258B (zh) 2022-11-21
CA2884066C (en) 2021-08-10
EP3354747A1 (en) 2018-08-01
IL237495B (en) 2019-09-26
WO2014043763A1 (en) 2014-03-27
BR112015006183A2 (pt) 2017-07-04
MY187444A (en) 2021-09-22
LT3354747T (lt) 2021-04-12
ZA201501772B (en) 2016-10-26
SG10201705198UA (en) 2017-07-28
IL299444A (en) 2023-02-01
KR20200085928A (ko) 2020-07-15
DK3536807T3 (da) 2024-02-05
PL2898100T5 (pl) 2023-11-06
HRP20241142T1 (hr) 2024-11-22
EP4335929B1 (en) 2026-01-21
AU2017251832B2 (en) 2019-10-10
PT2898100T (pt) 2018-02-26
KR20150082228A (ko) 2015-07-15
HRP20210716T1 (hr) 2021-06-11
MY173356A (en) 2020-01-21
KR102148547B1 (ko) 2020-08-26
PL3354747T3 (pl) 2021-07-26
PL4056712T3 (pl) 2024-12-02
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
EP4335929A3 (en) 2024-05-29
NZ717423A (en) 2017-08-25
AU2013317708C1 (en) 2017-11-23
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
LT4056712T (lt) 2024-09-10
EP4335929A2 (en) 2024-03-13
CN104781422B (zh) 2023-12-26
AU2022201026B2 (en) 2025-04-03
BR122021021823B1 (pt) 2023-04-25
TWI901957B (zh) 2025-10-21
KR20220065034A (ko) 2022-05-19
MX360034B (es) 2018-10-19
CA2884066A1 (en) 2014-03-27
PT3536807T (pt) 2024-02-01
IL313451A (en) 2024-08-01
HK1257868A1 (en) 2019-11-01
SMT202100256T1 (it) 2021-05-07
JP2015536639A (ja) 2015-12-24
JP2022031753A (ja) 2022-02-22
BR112015006183B1 (pt) 2022-04-26
EA201500327A1 (ru) 2015-07-30
AU2013317708A1 (en) 2015-04-09
JP7594817B2 (ja) 2024-12-05
JP2024009833A (ja) 2024-01-23
CA3122779A1 (en) 2014-03-27
IL268512A (en) 2019-09-26
PH12015500547A1 (en) 2015-05-04
JP2018121644A (ja) 2018-08-09
JP2020108400A (ja) 2020-07-16
IL268512B2 (en) 2023-06-01
FI4056712T3 (fi) 2024-08-29

Similar Documents

Publication Publication Date Title
IL268512A (en) Non-invasive determination of fetal or tumor methylation from plasma
IL288181A (en) Cancer treatment methods
IL232530A0 (en) Combined cancer treatment
ZA201307036B (en) Treatment of solid tumours
IL228430A0 (en) Cancer treatment
EP2903644A4 (en) TREATMENT OF CANCER
GB201217892D0 (en) Treatment of cancer
GB201217890D0 (en) Treatment of cancer
GB201222952D0 (en) Treatent of cancer
GB201208296D0 (en) Treatment of cancer
GB201222949D0 (en) Combination Treatment of Cancer
GB201222950D0 (en) Combination treatment of cancer
IL229109A0 (en) Cancer diagnosis
GB201121791D0 (en) Combination treatment of cancer
GB201121783D0 (en) Treatment of cancer
ZA201104679B (en) Suppression of cancers